<DOC>
	<DOC>NCT00330824</DOC>
	<brief_summary>Efficacy/Safety of antibiotic steroid combination compared with individual administration in inflammation Post-LASIK</brief_summary>
	<brief_title>Efficacy/Safety of Antibiotic Steroid Combination in Prevention of Post Operative Inflammation in LASIK Surgery</brief_title>
	<detailed_description>antibiotic/steroid combination compared to individuals components 15 days of treatment</detailed_description>
	<mesh_term>Inflammation</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>Moxifloxacin</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<mesh_term>Fluoroquinolones</mesh_term>
	<mesh_term>Anti-Bacterial Agents</mesh_term>
	<mesh_term>Antibiotics, Antitubercular</mesh_term>
	<mesh_term>Norgestimate, ethinyl estradiol drug combination</mesh_term>
	<criteria>patients having LASIK surgery; men or women of any race, between 18 and 50 years old, presenting up to 8 degrees of myopia or up to 4 degrees of hypermetropia, or up to 3 degrees of astigmatism, without any other associated ocular problems Uncontrolled glaucoma or intraocular hypertension; Use of any ocular antiinfectious drugs or any topical or systemic ocular NSAIDs during the study but study drugs; A history of chronic or recurrent ocular inflammatory disease; Uncontrolled diabetes mellitus and diabetic retinopathy ; Patients with sight in a single eye; Iris atrophy in the eye to be operated; Pregnant or lactating women, or women of childbearing potential who are not using proper birthcontrol methods; Known or suspected allergy or hypersensitivity to any component of study medication; A history or any other evidence of severe systemic disease</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>50 Years</maximum_age>
	<verification_date>August 2009</verification_date>
	<keyword>prevention of post inflammation in LASIK surgery</keyword>
</DOC>